AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 135 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $37,000 | -24.5% | 1,948 | -11.0% | 0.00% | -33.3% |
Q2 2020 | $49,000 | +2.1% | 2,189 | -10.1% | 0.00% | +50.0% |
Q3 2019 | $48,000 | -61.6% | 2,435 | -59.0% | 0.00% | -66.7% |
Q2 2019 | $125,000 | -31.7% | 5,935 | -33.6% | 0.01% | -40.0% |
Q1 2019 | $183,000 | +157.7% | 8,935 | +151.9% | 0.01% | +100.0% |
Q4 2018 | $71,000 | +115.2% | 3,547 | +102.7% | 0.01% | +150.0% |
Q1 2018 | $33,000 | -2.9% | 1,750 | -24.8% | 0.00% | -33.3% |
Q1 2017 | $34,000 | -82.0% | 2,326 | -77.3% | 0.00% | -87.0% |
Q4 2016 | $189,000 | -64.1% | 10,269 | -63.0% | 0.02% | -58.2% |
Q3 2016 | $526,000 | +54.7% | 27,718 | +31.5% | 0.06% | +14.6% |
Q2 2016 | $340,000 | +48.5% | 21,078 | +10.5% | 0.05% | +50.0% |
Q1 2016 | $229,000 | -39.3% | 19,078 | -27.9% | 0.03% | -44.8% |
Q4 2015 | $377,000 | +53.3% | 26,478 | +25.6% | 0.06% | +61.1% |
Q3 2015 | $246,000 | – | 21,078 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MQS Management LLC | 10,935 | $255,000 | 0.41% |
GLOBEFLEX CAPITAL L P | 144,692 | $3,370,000 | 0.34% |
CORNERCAP INVESTMENT COUNSEL INC | 58,975 | $1,374,000 | 0.20% |
Factorial Partners, LLC | 10,900 | $254,000 | 0.17% |
FEDERATED HERMES, INC. | 3,464,335 | $80,684,000 | 0.15% |
Campbell & CO Investment Adviser LLC | 14,800 | $345,000 | 0.12% |
FULLER & THALER ASSET MANAGEMENT, INC. | 611,462 | $14,241,000 | 0.08% |
Summit Global Investments | 45,900 | $1,069,000 | 0.07% |
RENAISSANCE GROUP LLC | 63,559 | $1,480,000 | 0.06% |
PDT Partners, LLC | 33,459 | $779,000 | 0.06% |